Literature DB >> 1657923

Molecular cloning and expression of platelet-activating factor receptor from human leukocytes.

M Nakamura1, Z Honda, T Izumi, C Sakanaka, H Mutoh, M Minami, H Bito, Y Seyama, T Matsumoto, M Noma.   

Abstract

The cDNA for a platelet-activating factor (PAF) receptor was cloned from a human leukocyte cDNA library using a 0.8-kilobase pair fragment of the guinea pig lung PAF receptor cDNA (Honda, Z., Nakamura, M., Miki, I., Minami, M., Watanabe, T., Seyama, Y., Okado, H., Toh, H., Ito, K., Miyamoto, T., and Shimizu, T. (1991) Nature 349, 342-346). The cDNA (1.8-kilobase pairs) had an open reading frame encoding 342 amino acid residues with a calculated Mr of 39,203. The clone was shown to code for a PAF receptor based on the following criteria: 1) the amino acid sequence possesses seven putative membrane spanning domains with 83% identity to the guinea pig lung PAF receptor, 2) Xenopus laevis oocytes injected with the transcript of the clone showed an electrophysiological response to PAF, and 3) COS-7 cells expressing the encoded receptor showed ligand binding with the pharmacological properties of the PAF receptor. Activation of the PAF receptor yielded inositol 1,4,5-trisphosphate production in both COS-7 cells and oocytes, and guanosine 5'-O-(2-thio)bisphosphate injection into the oocytes inhibited PAF-induced Cl- current, providing an evidence that PAF stimulates phosphoinositide turnover via G-protein(s). PAF receptor mRNA was abundant in leukocytes and less so in an undifferentiated human eosinophilic cell line (EoL-1 cells) or human erythroleukemia cells (HEL cells). The production of the mRNA was prominently increased when EoL-1 cells were treated with granulocyte macrophage colony stimulating factor, interleukin-5, and n-butyrate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657923

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.

Authors:  G Montrucchio; E Lupia; A de Martino; E Battaglia; M Arese; A Tizzani; F Bussolino; G Camussi
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage.

Authors:  G Herrero-Beaumont; J Egido
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Amino acid residues critical for endoplasmic reticulum export and trafficking of platelet-activating factor receptor.

Authors:  Nobuaki Hirota; Daisuke Yasuda; Tomomi Hashidate; Teruyasu Yamamoto; Satoshi Yamaguchi; Teruyuki Nagamune; Takahide Nagase; Takao Shimizu; Motonao Nakamura
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

5.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Reduction by inhibitors of mono(ADP-ribosyl)transferase of chemotaxis in human neutrophil leucocytes by inhibition of the assembly of filamentous actin.

Authors:  J R Allport; L E Donnelly; B P Hayes; S Murray; N B Rendell; K P Ray; J MacDermot
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.

Authors:  Katherine M Howard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

8.  Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells.

Authors:  B Moser; L Barella; S Mattei; C Schumacher; F Boulay; M P Colombo; M Baggiolini
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

9.  Identification and functional characterization of platelet-activating factor receptors in human leukocyte populations using polyclonal anti-peptide antibody.

Authors:  E Müller; P Dagenais; N Alami; M Rola-Pleszczynski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Authors:  Vladislava O Melnikova; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Microenviron       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.